Phase I clinical evaluation of a new iron oxide MR contrast agent

Journal of Magnetic Resonance Imaging

Volumn 4, Issue 3, 1994, Pages 301-307

  McLachlan, Stuart J ^a   Morris, Marie R ^a   Lucas, Maria A ^a   Fisco, Ricardo A ^a   Eakins, Michael N ^a   Fowler, Dennis R ^a   Scheetz, R Bradley ^a   Olukotun, Adeoye Y ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

Contrast enhancement; Contrast media, effects; Contrast media, experimental studies; Contrast media, toxicity; Iron

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; IRON; OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ADULT; ARTICLE; BLOOD; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HEART RATE; HUMAN; MALE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 1 CLINICAL TRIAL;

ADULT; BLOOD PRESSURE; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MALE; OXIDES;

EID: 0028432559     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.1880040313     Document Type: Article

References (18)

1. The magnetic properties of some materials affecting MR images
2. Superparamagnetic iron oxide: pharmacokinetics and toxicity
3. Detection of liver metastases with superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5 T
4. Efficacy of superparamagnetic iron oxide as an adjunct to MR imaging of the liver: results of a multicenter trial (abstr)
5. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging
6. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging
7. Lymph nodes: microstructural anatomy at MR imaging
8. Bone marrow: ultrasmall superparamagnetic iron oxide for MR imaging
9. MR receptor imaging: ultrasmall iron oxide particles targeted to asialoglycoprotein receptors
10. Receptor imaging: application to MR imaging of liver cancer
11. Antimyosin‐labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging
12. Polyclonal human immunoglobulin‐G labeled with polymeric iron oxide: antibody MR imaging
13. The biodistribution of an ultrasmall superparamagnetic iron oxide colloid, BMS 180549, by different routes of administration
14. Dual contrast enhancement of both T1 and T2‐weighted sequences using ultrasmall superparamagnetic iron oxide
15. Dextran coated superparamagnetic iron oxide: the first human use of a new MR contrast agent for assessing lymph nodes in the head and neck
16. Enhancement of MR angiography with iron oxide: preliminary studies in whole blood phantoms and in animals
17. MR lymphography with superparamagnetic iron oxide nanoparticles in rats: pathologic basis for contrast enhancement